![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 18, 14718-14727, May 4, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Wake Forest University School of Medicine, Department of
Biochemistry, Winston-Salem, North Carolina 27157
The TREX1 and TREX2 genes encode mammalian
3'
Structure and Expression of the TREX1 and TREX2 3'
5'
Exonuclease Genes*
5' exonucleases. Expression of the TREX genes in human cells was
investigated using a reverse transcription-polymerase chain reaction
strategy. Our results show that TREX1 and TREX2 are expressed in all
tissues tested, providing direct evidence for the expression of these genes in human cells. Potential transcription start sites are identified for the TREX genes using rapid amplification of cDNA ends to recover the 5'-flanking regions of the TREX transcripts. The
5'-flanking sequences indicate transcription initiation from consensus putative promoters identified
140 and
650 base pairs upstream of the TREX1 open reading frame (ORF) and
623 and
753 base
pairs upstream of the TREX2 ORF. Novel TREX1 and TREX2 cDNAs are
identified that contain protein-coding sequences generated from exons
positioned in genomic DNA up to 18 kilobases 5' to the TREX1 ORF and up
to 25 kilobases 5' to the TREX2 ORF. These novel cDNAs and
sequences in the GenBankTM data base indicate that transcripts
containing the TREX1 and TREX2 ORFs are produced using a variety of
mechanisms that include alternate promoter usage, alternative splicing,
and varied sites for 3' cleavage and polyadenylation. These initial
studies have revealed previously unrecognized complexities in the
structure and expression of the TREX1 and TREX2 genes.
*
This work was supported by National Institutes of Health
Grants CA75350 and CA12197.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
336-716-4349; Fax: 336-716-7200; E-mail:
fperrino@wfubmc.edu.
This article has been cited by other articles:
![]() |
D. A. Lehtinen, S. Harvey, M. J. Mulcahy, T. Hollis, and F. W. Perrino The TREX1 Double-stranded DNA Degradation Activity Is Defective in Dominant Mutations Associated with Autoimmune Disease J. Biol. Chem., November 14, 2008; 283(46): 31649 - 31656. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. Perrino, U. de Silva, S. Harvey, E. E. Pryor Jr., D. W. Cole, and T. Hollis Cooperative DNA Binding and Communication across the Dimer Interface in the TREX2 3' -> 5'-Exonuclease J. Biol. Chem., August 1, 2008; 283(31): 21441 - 21452. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Chen, L. C. Dumitrache, D. Wangsa, S.-M. Ma, H. Padilla-Nash, T. Ried, and P. Hasty Cisplatin Depletes TREX2 and Causes Robertsonian Translocations as Seen in TREX2 Knockout Cells Cancer Res., October 1, 2007; 67(19): 9077 - 9083. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Chen, S.-M. Ma, L. C. Dumitrache, and P. Hasty Biochemical and cellular characteristics of the 3' -> 5' exonuclease TREX2 Nucleic Acids Res., April 10, 2007; (2007) gkm151v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morita, G. Stamp, P. Robins, A. Dulic, I. Rosewell, G. Hrivnak, G. Daly, T. Lindahl, and D. E. Barnes Gene-Targeted Mice Lacking the Trex1 (DNase III) 3'->5' DNA Exonuclease Develop Inflammatory Myocarditis Mol. Cell. Biol., August 1, 2004; 24(15): 6719 - 6727. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Mazur and F. W. Perrino Excision of 3' Termini by the Trex1 and TREX2 3'right-arrow5' Exonucleases. CHARACTERIZATION OF THE RECOMBINANT PROTEINS J. Biol. Chem., May 11, 2001; 276(20): 17022 - 17029. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |